Complement inhibition in pediatric ANCA-associated vasculitis
Curr Opin Immunol. 2026 Sep 10;103:102839. doi: 10.1016/j.coi.2026.102839. Online ahead of print. ABSTRACT Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) in childhood is a rare but severe condition associated with significant morbidity and treatment-related toxicity. Current therapies mainly rely on high-dose glucocorticoids and conventional immunosuppressants, which may cause substantial long-term adverse effects in pediatric patients. Advances … Read more